Statistical controversies in clinical research: an initial evaluation of a surrogate end point using a single randomized clinical trial and the Prentice criteria-Reference-Cited by-同舟云学术

Statistical controversies in clinical research: an initial evaluation of a surrogate end point using a single randomized clinical trial and the Prentice criteria

Published:2015-10 Issue:10 Volume:26 Page:2012-2016
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Heller G.

Funder

MSKCC SPORE in Prostate Cancer

Department of Defense Prostate Cancer Research Program

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/26/10/2012/337009/mdv333.pdf

Reference14 articles.

1. The validation of surrogate endpoints in meta-analyses of randomized experiments;Buyse;Biostatistics,2000

2. Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials;Shi;Int J Clin Oncol,2009

3. Surrogate endpoints in clinical trials: definitions and operational criteria;Prentice;Stat Med,1989

4. Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99–16;Petrylak;J Natl Cancer Inst,2006

5. Absence of evidence is not evidence of absence;Altman;Br Med J,1995

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Considerations for using potential surrogate endpoints in cancer screening trials;The Lancet Oncology;2024-05

2. An Overview of Phase 2 Clinical Trial Designs;International Journal of Radiation Oncology*Biology*Physics;2022-01

3. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework;Health Technology Assessment;2021-12

4. US Food and Drug Administration Approval of Aducanumab—Is Amyloid Load a Valid Surrogate End Point for Alzheimer Disease Clinical Trials?;JAMA Neurology;2021-11-01

5. Methoden klinischer Prüfung in der Onkologie;Springer Reference Medizin;2021